Full Breakdown
Harvey Price’s First Weight-Loss Gains After Starting Mounjaro
By Drooid · · How we work
A New Milestone in a Long-Running Health Battle
Harvey Price, 24, the son of former glamour model Katie Price, has begun to lose weight after his medical team prescribed the injectable diabetes drug Mounjaro for obesity management. In a recent episode of *The Katie Price Show* podcast, Katie announced that her son has already shed two stone since the treatment began and that the change is becoming visible.
Background: Prader-Willi Syndrome and Persistent Weight Gain
Harvey was diagnosed with Prader-Willi syndrome, a rare genetic disorder that drives an insatiable appetite and contributes to severe obesity. He also lives with autism, septo-optic dysplasia (which has left him partially blind), ADHD and oppositional-defiant disorder. Katie has publicly described his weight as “morbidly obese,” noting that in April 2025 his scale read almost 30 stone. Earlier dietary adjustments in 2025 helped him lose about 1.5 stone, but his weight soon returned to the 28-stone range, a level he had first reached in late 2020 at age 18.
Data & Statistics
- Weight before medication: reported between “almost 30 stone” (April 2025) and “28 stone” (multiple sources).
- Weight loss since Mounjaro: two stone lost, confirmed by Katie on the podcast.
- Body-mass index (BMI): reported as 59, classifying him as morbidly obese.
- Risk assessment: doctors warned that his size placed him at high risk of a heart attack.
Official Statements & Responses
Katie Price has repeatedly emphasized that any medication must be administered under professional supervision. She explained that doctors initially pursued dietary measures before considering pharmacologic options, and that the decision to start Mounjaro came after months of advocacy on her part.
Medical professionals, as relayed by Katie, have indicated that the primary goal of Mounjaro is to reduce Harvey’s weight to lower his cardiovascular risk. She has also noted that the treatment is part of a broader care plan that must be coordinated with his existing medication regimen.
Conflicting Reports & Gaps
- Weight figures: Some outlets cite Harvey’s weight as “28 stone,” while others describe it as “almost 30 stone” in April 2025. A third source specifies “28 stone 7 lb.” The exact current weight is therefore unclear.
- Timeline of medication start: Katie’s statements suggest the injections began shortly before the podcast interview, but precise timing is not detailed.
- Long-term efficacy: No data are provided on expected weight-loss trajectories or how long the current two-stone reduction will continue.
Why It Matters
Harvey’s weight loss is significant because his obesity, compounded by Prader-Willi-related hyperphagia, has placed him at a heightened risk of cardiovascular events. Reducing his weight may improve breathing during sleep, increase mobility, and lessen the burden on his caregivers. The case also highlights the challenges families face when seeking off-label use of diabetes medications for rare genetic conditions.
Verbatim Quotes
- “It's easy for me to just give it, but because of his other medications, you have to have all the team tick it off. It's getting to a point now, where he doesn't want to walk anywhere, he gets out of breath and sweats and they have said he is at high risk of having a heart attack.” — Harvey's Mounjaro — Harvey's Mounjaro
- “Harvey is starting the Mounjaro. I can’t wait.” — Again — Again